CompletedNCT02582905
Citicoline or Pregnenolone for Alcohol Use in Bipolarity
About this title
Read the official source — NCT02582905Medication studyAges 18–70United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 70 years.
- Listed locations
- Miami and 2 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: May 2016
- Recruitment status
- Completed
- Enrollment listed in the registry
- 96
- Sponsor
- Sherwood Brown, MD, PhD
- Sponsor type
- Individual investigator
- Study type
- Drug
- Intervention type
- Dietary supplement, Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT02582905
- Official title
Show the full official title
Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Miami · Dallas · Edinburg
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Sherwood Brown, MD, PhD.
Did this study involve medication?
Yes. The study involved medication, including Placebo and Pregnenolone.
Who was this study for?
Listed age limits: 18 years to 70 years.
